Anzeige
Meldung des Tages: Diese Goldaktie startet NI-43-101 Ressourcenschätzung – jetzt kann aus der Story Substanz werden

Oncolytics Biotech Aktie News

Aktie
WKN:  A2JMW5 ISIN:  CA6823108759 US-Symbol:  ONCY Branche:  Biotechnologie Land:  Kanada
1,11 $
-0,05 $
-4,31%
0,9256 € 28.01.26
Depot/Watchlist
Marktkapitalisierung *
62,33 Mio. €
Streubesitz
94,71%
KGV
-3,21
Index-Zuordnung
Nasdaq Composite Index

Oncolytics Biotech News

28.01.26 - PR Newswire
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
Late-​Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment PR Newswire
28.01.26 - PR Newswire
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
Late-​Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment PR Newswire
27.01.26 - PR Newswire
Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
Registration-​Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks PR Newswire
14.01.26 - PR Newswire
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire
12.01.26 - PR Newswire
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026
Fast-​Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 PR Newswire
07.01.26 - PR Newswire
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
How $594B in Precision Tech is Cracking the Metastatic Cancer Code PR Newswire
31.12.25 - PR Newswire
Smart Oncology: 5 Stocks Chasing the $317B Prize
Smart Oncology: 5 Stocks Chasing the $317B Prize PR Newswire
16.12.25 - PR Newswire
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B PR Newswire
12.12.25 - PR Newswire
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PR Newswire
28.10.25 - PR Newswire
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care
Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care PR Newswire
20.10.25 - PR Newswire
Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada
Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada PR Newswire
29.09.25 - PR Newswire
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
Oncolytics Biotech® Announces Update for Potential First-​Line Pancreatic Cancer Registration Study PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
16.09.25 - PR Newswire
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals PR Newswire
16.09.25 - PR Newswire
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion PR Newswire
08.09.25 - PR Newswire
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market PR Newswire
08.09.25 - PR Newswire
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market PR Newswire
08.09.25 - PR Newswire
Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions
Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions PR Newswire
02.09.25 - PR Newswire
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands PR Newswire
02.09.25 - PR Newswire
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands PR Newswire

Newssuche

Videos

newspaper
27.01.26 +3,71%
Technical Trading: Pfund Short
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »